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ABSTRACT 
Objective: This study aims to control type 2 of diabetes mellitus by a hypoglycemic substance that extensively produced by Streptomyces bacteria. 
The antidiabetic action of this substance depends on prevention of starch hydrolysis and then the liberation of glucose monomers via an inhibition 
of α-glucosidase as one of starch hydrolyzing enzymes. 
Methods: The strains of marine actinomycetes were isolated on starch nitrate agar, and then qualitatively and quantitatively screened to prevent 
starch hydrolysis. The most potent strain was identified by classical and genetical methods. The genetic improvement of the most potent strain was 
carried out by using UV radiations at different exposure periods per second. The optimization of environmental conditions was studied to obtain the 
maximum activity of the α-glucosidase inhibitory protein, which purified and electrically separated to determine its molecular weight.  
Results: Among 55 marine actinomycetes, only 7 strains were found have antidiabetic activity. This activity was assayed spectrophotometrically at 400 
nm, where p-nitrophenyl-α-d-glucopyranoside and acarbose were used as a substrate and a positive control respectively. The most potent strain which 
marked as AD-7 was identified as Streptomyces coelicolor, which exposed to the genetic improvement using UV radiations to obtain a highly activity of an 
inhibitory protein at 10 s of the exposure period. The activity and stability continued for 5 d at 37 °C. The maximum activity and stability of an improved 
inhibitory protein were obtained with optimization of environmental conditions included inoculum size (106
Conclusion: Alpha-glucosidase inhibitory protein as a powerful hypoglycemic agent was extracted from the filtrate of S. coelicolor. The mutant 
strain of the latter had been produced most active and stable inhibitory protein, which prevents the starch hydrolysis via an inhibition of α-
glucosidase enzyme for 5 d at 37 °C.  
 cfu/ml/300 µl), incubation period (14 d), 
agitation speed (160 rpm), incubation temperature (30 °C), and pH (8.5). An inhibitor was purified and separated at 34 KDa.  
Keywords: Antidiabetic agents, Diabetes mellitus, Enzyme inhibitors, Physical mutagenesis, Starch hydrolysis 




Diabetes mellitus (DM) is a chronic disease arises from metabolic 
disorders, especially in the pancreatic gland. Simply, DM is an 
elevation of blood glucose level all the time (hyperglycemia) due to 
either deficient pancreatic insulin secretion or failed blood-insulin 
absorption [1]. So, the blood glucose level must be under full control 
to avoid the serious complications. There are two types of medical 
complications resulted from uncontrolled DM; acute complications 
such as diabetic ketoacidosis, hyperosmolar hyperglycemic state, or 
death, and chronic complications such as stroke, foot ulcers (diabetic 
foot), kidney failure, blindness, impotence, cardiovascular disease 
and gangrene. Uncontrolled DM has some symptoms such as 
frequent urination, increased thirst, increased hunger, and body 
weight loss [2]. Norman [3] stated that, according to the last report 
of WHO, number of diabetes up to 2010 was 285 million and will be 
438 million at 2030 worldwide. Bailey and Day [4] reported that, 
there are three main types of DM; type 1 is called insulin-dependent 
diabetes mellitus (IDDM) or juvenile diabetes, in which the insulin 
secretion is completely stopped due to unknown reasons; type 2 is 
called non-insulin-dependent diabetes mellitus (NIDDM) or adult-
onset diabetes, in which the sufficient amount of insulin does not 
deliver to the blood due to failure of cell receptors-insulin contact. 
The main reason of type 2 is excessive obesity; and the last type is 
called gestational diabetes that associated with pregnancy without 
previous history of diabetes. Moreover, there are other uncommon 
types of DM; prediabetes in which the blood glucose level is 
increased but did not reach to type 2 level. Nevertheless, prediabetes 
may be developed to type 2. Another uncommon type of DM called 
latent autoimmune diabetes of adults (LADA), which be latent in the 
adult and then developed to type 1. Sometimes LADA is 
misdiagnosed as having type 2 of DM. Type 3 of diabetes is called 
Alzheimer's disease in which insulin resistance by the brain is 
present [5]. A non-diabetic person has a normal level of blood 
glucose ranged from 80 to 120 mg/dl. On the other hand, the normal 
level of blood glucose with a diabetic person is up to 180 mg/dl [6]. 
One of the antidiabetic approaches related to DM type 2 is an 
inhibition of starch hydrolyzing enzymes like α-amylase and α-
glucosidase [7], which responsible for the liberation of disaccharides 
and glucose monomers respectively [8]. Alpha-glucosidase 
(EC3.2.1.20) is a starch hydrolyzing enzyme that catalyzes splitting 
of disaccharides and oligosaccharides and liberation of glucose 
monomers in the small intestine [9]. Therefore, all inhibitors of this 
enzyme are antidiabetic agents which aid in the control of the blood 
glucose level. Among of α-glucosidase inhibitors, acarbose, 
voglibose, and miglitol. Acarbose and voglibose are not absorbed 
from the intestine and excreted through the faecal route, so they 
have poor bioavailability; however, miglitol is completely absorbed 
from the upper part of the intestine and excreted by the kidneys 
[10]. Although poor bioavailability of acarbose, it has many benefits 
including body weight loss, blood pressure adjustment, protection 
against heart diseases, and reduction of hypertriglyceridemia [11]. 
Acarbose is oral antidiabetic pharmaceutical product constituted of α-
glucosidase and α-amylase inhibitors produced by Actinoplanes 
utahensis [12, 13]. Voglibose is similar to acarbose, but it has only α-
glucosidase inhibitor as a single active ingredient that produced by 
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Streptomyces hygroscopicus-limoneus [14, 15]. Valienamine is a 
precursor of voglibose produced by Streptomyces calvus [16, 17], and 
adiposin-1, and trestatin-B produced by Streptomyces dimorphogenes 
[18, 19]. Although the high antidiabetic effect of these products, some 
adverse effects are found such as a headache, insomnia, vomiting, 
flatulence, and diarrhea [20]. Fortunately, the genetic exchange 
between the endophytic microbes and their antidiabetic hosts of 
medicinal plants plays an important role in the microbial production of 
antidiabetic agents; hence, the α-glucosidase inhibitor can be produced 
by endophytic microbes of antidiabetic medicinal plants [21-23]. This 
study aims to improve the activity and stability of α-glucosidase 
inhibitor that produced by marine actinomycetes.  
MATERIALS AND METHODS 
Chemicals and reagents 
The sigma company was the single source of the following chemicals:  
• Soluble starch, potassium nitrate, and dipotassium hydrogen 
orthophosphate.  
• Calcium carbonate, magnesium sulphate, sodium chloride.  
• Bacteriological agar.  
• The alpha-glucosidase enzyme, p-nitrophenyl-α-d-gluco-
pyranoside, and acarbose. 
• Iodine solution and magnesium chloride. 
• Forward primer 5’-AGAGTTTGATCCTGGCTCAG-3’. 
• Reverse primer 5’-AAGGAGGTGATCCAGCC-3’. 
• Master Mix. 
• Chloroform, phenol, and ethanol. 
• RNase, TE buffer, proteinase K, and DNA ladder. 
• Sodium dodecyl sulphate. 
• Diethyl-aminoethyl-cellulose and sephadex G 200. 
• Polyacrylamide gel. 
• Folin reagent, copper sulphate, and bovine serum albumin. 
• Streptomycin and amoxicillin powder. 
• Tryptone, peptone, glycerol, and tyrosine. 
• Yeast, malt, and oat extracts. 
• Czapek's agar medium. 
• Xanthin and esculin. 
• Set of sugars. 
• Set of amino acids. 
• A mixture of L and meso-Diaminopimelic acid. 
Methodology 
Isolation of marine actinomycetes 
The sediment samples of the Red Sea were collected in sterile plastic 
bags which preserved at 4 °C, and then transported to the 
laboratory. All samples were dried in the air at room temperature 
for overnight. Isolation of marine actinomycetes was carried out on 
starch nitrate agar contained 10% NaCl by serial dilution method 
[24]. All strains were purified, subcultured, and maintained on the 
slants of the same medium and preserved at 4 °C.  
Screening test 
All strains of marine actinomycetes were qualitatively screened to 
inhibit the starch hydrolyzing enzymes included α-glucosidase. All of 
them were grown on starch nitrate broth contained 10% NaCl, and 
then incubated with shaking at 30 °C and 160 rpm for 14 d. The 
suspension of each strain was centrifuged at 5000 xg for 10 min. The 
pellet was discarded, but the supernatant was pooled and filtered 
twice through the filter paper (Whatman No.1) to obtain the cell-free 
extract. The procedure was conducted as the following: There 3 clear 
glass test tubes were used with each cell-free extract; each tube 
contained 5 ml of starch solution. The first tube (a) was supplemented 
with 1 u/ml of α-glucosidase enzyme as a negative control, while the 
second tube (b) was supplemented with 1u/ml of α-glucosidase and 1 
mg/ml of acarbose (α-glucosidase inhibitor) (Sigma http://www, 
chemicalinfo. com/DWCP) as a positive control, and the third tube (c) 
was supplemented with 1 u/ml of α-glucosidase and 1 ml of cell-free 
extract. All tubes were left at room temperature for 10 min, and then 
incubated at 37 °C for 3 h. Starch hydrolysis was detected in all tubes 
by using iodine solution. The blue color was absent in the tube (a) due 
to complete starch hydrolysis via α-glucosidase activity; while, the 
dark blue color was present in the tube (b) due to complete inhibition 
of α-glucosidase activity via acarbose (α-glucosidase inhibitor). The 
ability of test organism to inhibit α-glucosidase or not was clearly 
determined according to the observation in tube (c); where, absence of 
blue color is a negative result; while, presence of dark blue color is a 
positive result. All tubes (c) of positive results were further incubated 
at 37 °C and examined each 24 h. The most potent strain was selected 
according to the dark blue color which remained a longest period at 37 
°C [25].  
Assay of α-glucosidase inhibition 
The screening test was further conducted by quantitative method. The 
activity of α-glucosidase inhibitor was measured according to Anam et 
al. [25]; where α-glucosidase (0.75 u/ml) was dissolved in 0.1 M 
phosphate buffer pH 7.0. Also, p-nitrophenyl-α-d-glucopyranoside (20 
mmol) was dissolved in 0.1 M phosphate buffer pH 7.0. The reaction 
mixture was prepared by adding 125 µl of p-nitrophenyl-α-d-
glucopyranoside, 240 µl of 0.1 M phosphate buffer pH 7.0 and 10 µl 
sample, and then incubated at 37 °C for 5 min, and then 125 µl of α-
glucosidase were added and incubated for 15 min at 37 °C. The 
reaction was stopped by addition of 500 µl sodium carbonate. The 
reaction product is p-nitrofenol which was measured colourimetrically 
at 400 nm. As a comparison, we used 1 mg/ml solution of acarbose. 
This experiment has been repeated at different incubation periods of 
cell-free extract of each strain to exact determine the stability of each 
inhibitor. The activity of α-glucosidase inhibitory protein was 
determined by the following equation:  
𝐼𝐼𝐼𝐼ℎ𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝐼𝐼 (%) =
𝐴𝐴𝐴𝐴 − (𝐴𝐴𝐴𝐴 − 𝐴𝐴𝑖𝑖)
𝐴𝐴𝐴𝐴 × 100
 
(Ac: absorbance of control, Ab: absorbance of background, As: 
absorbance of the sample). 
Identification of actinomycete isolate 
Classical techniques 
The most potent actinomycete strain AD-7 was identified by 
determination of morphological, physiological, and cultural 
characteristics according to Shirling and Gottlieb [26]. Inorganic salt 
starch agar (ISP-4) was used for cultivation and characterization of 
actinomycete strain by scanning electron microscopy.  
DNA extraction 
Actinomycete isolate was inoculated aseptically in 250 ml Erlenmeyer 
flask contained 30 ml of starch nitrate broth, and then incubated with 
shaking at 30 °C and 160 rpm for 14 d. The bacterial suspension was 
centrifuged at 10 000 xg for 10 min. The supernatant was discarded, 
and only 0.1 g of precipitated mycelia were transferred to sterile 
porcelain dish and crushed with liquid nitrogen. The crushed mycelia 
were transferred to clear tube containing 500 μl of TE buffer 
supplemented with lysozyme (20 mg/ml). The tube was incubated at 
37 °C for 30 min, and then supplemented with 20 μl of 10% SDS (w/v) 
and 20 μl of proteinase K, and then incubated at 55 °C for 30 min. The 
lysate was cooled down and extracted once with an equal volume of 
phenol: chloroform solution (v/v 1:1) at 10 000 xg for 5 min. The 
aqueous phase was transferred carefully to clear tube and DNA was 
precipitated by adding 70-90% ethanol and keeping at-20 °C for 30 
min. The pellet was formed by centrifuging at 10 000 xg for 10 min. 
The pellet was washed twice with 90% ethanol and dissolved the 
pellet in TE buffer [27]. 
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Polymerase chain reaction (PCR) technique was used to amplify 16S 
rRNA gene in a thermocycler (Perkin Elmer Cetus Model 480) by using 
the universal primer; the forward primer 5’-AGAGTTTGAT-
CCTGGCTCAG-3’ and the reverse primer 5’-AAGGAGGTGATCCAGCC-3’ 
[28]. PCR reaction was performed in a total volume of 25 μl containing: 
2.5 μl PCR buffer, 1.5 mmol MgCl2, 200 μM dNTPs, 1 u Taq DNA 
polymerase (Ampli Taq, Perkin-Elmer), 2.5 μl of 10 p-mol each primer 
and 2.5 μl of the extracted bacterial DNA and the volume was 
completed to 25 μl using sterile distilled H2
Purification of α-glucosidase inhibitory protein 
O. PCR reaction conditions 
were approached as; one cycle of 94 °C for 5 min followed by 35 
cycles; each cycle consists of 94 °C for 1 min, 55 °C for 1 min, 72 °C for 
90 s. and a final extension step at 72 °C for 5 min. The PCR product 
(1500 bp) was directly sequenced by a BigDye terminator cycle 
sequencing kit (PE Applied Biosystems, Foster City, CA, USA) on an ABI 
310 automated DNA sequencer using both the reverse and forward 
primers (Applied Biosystems, Foster City, CA, USA).  
Optimization study 
Effect of incubation period 
There ten Erlenmeyer flasks (250 ml) contained 100 ml of starch nitrate 
broth at pH 7.2 were inoculated by equal inoculum of mutant 
actinomycete isolate AD-7, and then incubated with shaking at 30 °C and 
160 rpm for different incubation periods (2, 4, 6, 8, 10, 12, 14, 16, 18, and 
20 d). The antidiabetic activity was measured as mentioned above. 
Effect of incubation temperature 
There ten Erlenmeyer flasks (250 ml) contained 100 ml of starch 
nitrate broth at pH 7.2 were inoculated by equal inoculum of mutant 
actinomycete isolate AD-7, and then incubated with shaking at 160 
rpm for different incubation temperature (22, 24, 26, 28, 30, 32, 34, 
36, 38, and 40 °C) for 14 d. The antidiabetic activity was measured as 
mentioned above. 
Effect of initial pH values 
There ten Erlenmeyer flasks (250 ml) contained 100 ml of starch 
nitrate broth. Each medium was adjusted at definite pH (5, 5.5, 6, 
6.5, 7, 7.5, 8, 8.5, 9, and 9.5). All flasks were inoculated by an equal 
inoculum of mutant actinomycete isolate AD-7, and then incubated 
with shaking at 160 rpm and 30 °C for 14 d. The antidiabetic activity 
was measured as mentioned above. 
Effect of agitation speed 
There six Erlenmeyer flasks (250 ml) contained 100 ml of starch nitrate 
broth at pH 7.2 were inoculated by equal inoculum of mutant 
actinomycete isolate AD-7, and then incubated with shaking at 30 °C and 
at different agitation speeds (120, 140, 160, 180, 200, and 220 rpm) for 
14 d. The antidiabetic activity was measured as mentioned above. 
Effect of inoculum size 
There ten Erlenmeyer flasks (250 ml) contained 100 ml of starch nitrate 
broth at pH 7.2 were inoculated by different inocula of mutant 
actinomycete isolate AD-7 (50, 100, 150, 200, 250, 300, 350, 400, 450, 
and 500 µl), and then incubated with shaking at 30 °C and 160 rpm for 
14 d. The antidiabetic activity was measured as mentioned above. 
The batch of starch nitrate broth (2 l) at pH 8.5 was inoculated by 
300 µl (106
The molecular weight of α-glucosidase inhibitory protein was 
determined by using sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE) according to Blackshear [32].  
 cfu/ml) of the mutant actinomycete isolate AD-7, and 
then incubated with shaking at 30 °C and 160 rpm for 14 d. After the 
incubation period, the bacterial suspension was centrifuged at 5000 
xg for 10 min. The pellet was discarded and supernatant contained 
α-glucosidase inhibitory protein was filtered through filter paper 
(Whatman No.1) to obtain clear cell-free extract. The cell-free 
extract was sequentially supplemented with different 
concentrations of saturated ammonium sulfate (10 to 90%). At each 
concentration, the mixture was preserved at 4 °C for 2 h. The 
mixture was centrifuged at 5000 xg for 20 min at 4 °C. The 
supernatant was discarded; while the precipitate was dissolved in 
10 ml phosphate buffer (pH 8.5). The total protein content of the 
cell-free extract (control) and of each fraction contained precipitated 
proteins was estimated according to Lowery et al. [29]. Ion-exchange 
column chromatography using di-ethyl-amino-ethyl cellulose as a 
resin was conducted according to Dale and Smith [30]. The active 
fractions were pooled and passed through sephadex G 200 to obtain 
purified protein according to Andrews [31]. 
Separation of α-glucosidase inhibitory protein 
RESULTS AND DISCUSSION 
Isolation of marine actinomycetes 
There 55 marine actinomycete strains were isolated from the 
sediment samples of the Red Sea. The isolation was carried out on 
starch nitrate agar contained 10% NaCl. All strains were picked up, 
purified, subcultured, and then preserved at 4 °C. Many therapeutic 
compounds including antidiabetics are highly producing by marine 
microorganisms [33], especially marine actinomycetes that usually 
isolated from soils or sediments of the sea [34]. Although marine 
actinomycetes are economic medical bacteria due to their highly 
production for medical substances particularly antimicrobial agents 
[35], they are not widely used as antidiabetic producers [36]. 
Screening test 
These strains were screened qualitatively to inhibit starch 
hydrolysis via inactivation of the α-glucosidase enzyme. Both of p-
nitrophenyl-α-d-glucopyranoside and acarbose were used as a 
substrate and an enzyme inhibitor respectively. The screening test 
resulted in only 7 antidiabetic strains are present; however, the 
highest activity and stability of an inhibitor were observed in the 
cell-free extract of the strain AD-7 (fig. 1a). Iodine solution was used 
as a reagent to detect the starch hydrolysis. So, the dark blue color 
that clearly appeared in the tube (a) referred to retarded starch 
hydrolysis by the action of the cell-free extract contained an α-
glucosidase inhibitor. On the other hand, the white color in the tube 
(b) referred to complete starch hydrolysis by the action of the α-
glucosidase enzyme. The dark blue color in the tube (a) remained at 
fifth day of incubation at 37 °C, and then disappeared gradually (fig. 
1b). Ganesan et al. [37] reported that there 4 strains among 30 ones 




Fig. 1: (a) Tube (a) inhibition of α-glucosidase activity by cell free extract of strain AD-7 up to fifth day of incubation at 37 °C; tube (b) 
hydrolyzed starch by α-glucosidase activity. (b) tube (a) disappearance of dark blue color after fifth day of incubation at 37 °C due to 
degradation of α-glucosidase inhibitor in the cell free extract of strain AD-7; tube (b) hydrolyzed starch by α-glucosidase activity, n = 1 
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Assay of α-glucosidase inhibition 
The quantitative screening test was carried out for all strains, where the 
activity of an inhibitor was measured colourimetrically at 400 nm (table 
1). Furthermore, the stability of α-glucosidase inhibitor was determined, 
where the more stable inhibitor was being active at the longest 
incubation period at 37 °C. The results of qualitative and quantitative 
tests were conformed with each other, where the same 7 antidiabetic 
strains were present; AD-4, AD-7, AD-16, AD-24, AD-31, AD-33, and AD-
40 strains were found has 2.3% at 3rd d, 4.2% at 5th d, 1.8% at 7th d, 1.0% 
at 4th d, 3.2% at 5th d, 3.0% at 5th d, and 2.7% at 6th
 
 d respectively. 
Accordingly, the strain AD-7 was considered the most potent due to the 
highest activity and more stability of α-glucosidase inhibitor, followed by 
AD-31, AD-33, AD-40, AD-4, AD-16, and AD-24 strains. Imada and Simidu 
[38] stated that, out of 30 strains of actinomycetes, there only 7 strains 
were found have the ability to decrease the blood glucose level in the rats 
by inhibition of α-glycosidase, while the others did not exhibit any 
activity. The most potent strain was symbolized as PSG-22, which had a 
highest in vitro and in vivo α-glucosidase inhibition activity. In vitro α-
glucosidase inhibition activity was showed with only 6 strains. 
Table 1: Assay the activity of the α-glucosidase inhibitor 
Strain No. Inhibition activity (%)/d 
1st 2  nd 3  rd 4  th 5  th 6  th 7  th 8  th 9  th 10  th  
AD (1-3) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
AD-4 1.2±0.10 1.8±0.15 2.3±0.15  2.0±0.12 1.6±0.11 1.2±0.10 0.7±0.08 0.5±0.05  0.3±0.02 0.0 
AD (5-6) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
AD-7 1.7±0.11 2.4±0.15 3.1±0.18 3.7±0.21 4.2±0.25 3.4±0.20 2.8±0.17 2.1±0.15 1.5±0.12 0.9±0.10 
AD (8-15) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
AD-16 0.1±0.01 0.3±0.01 0.5±0.02 0.8±0.03 1.4±0.11 1.6±0.11 1.8±0.12  1.2±0.10 0.6±0.02 0.0 
AD (17-23) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
AD-24 0.1±0.01 0.4±0.01 0.7±0.03 1.0±0.08 0.5±0.05  0.2±0.02 0.0 0.0 0.0 0.0 
AD (25-30) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
AD-31 0.3±0.01 0.7±0.03 1.5±0.11 2.8±0.15 3.2±0.20 2.1±0.15 1.4±0.11 0.8±0.07 0.3±0.02 0.0 
AD-32 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
AD-33 0.7±0.03 1.3±0.15 1.9±0.18 2.6±0.19 3.0±0.23 2.1±0.18 1.6±0.15 1.1±0.11 0.4±0.01 0.0 
AD (34-39) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
AD-40 0.3±0.01 0.5±0.02 0.8±0.04 1.7±0.11 2.3±0.19 2.7±0.22 2.0±0.18 1.2±0.10 0.5±0.02 0.0 
AD (41-55) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
n = 2;±SD 
 
Identification of actinomycete isolate  
The actinomycete strain AD-7 as a most potent antidiabetic one was 
identified classically according to Shirling and Gottlieb [26], where 
cultural characteristics were determined as shown in table 2. The 
cultural characteristics were determined by using seven growth 
media; tryptone-yeast extract agar, yeast-malt extract agar, oatmeal 
extract agar, inorganic salts starch agar, glycerol asparagine agar, 
peptone yeast extract iron agar and tyrosine agar media. The good 
growth with the light gray color of aerial mycelia and light gray 
yellowish-brown color of substrate mycelia and diffusible pigments 
were observed on tryptone-yeast extract agar, yeast-malt extract 
agar, and inorganic salts starch agar media. The oat-meal extract 
agar medium was found has a moderate growth with the light gray 
color of aerial mycelia, the light yellowish-brown color of substrate 
mycelia and light gray yellowish-brown color of diffusible pigments. 
The peptone yeast extracts iron agar medium was found has a 
moderate growth with the light gray color of aerial mycelia and light 
gray yellowish-brown color of both substrate mycelia and diffusible 
pigments. The poor growth with the light gray color of aerial mycelia 
and light gray yellowish-brown color of both substrate mycelia and 
diffusible pigments were observed on glycerol asparagine agar 
medium. The poor growth with the light gray color of aerial mycelia, 
the light yellowish-brown color of substrate mycelia and light gray 
yellowish-brown color of diffusible pigments were observed on 
tyrosine agar medium. 
The morphological, biochemical, and physiological characteristics 
were determined as shown in table 3. There 2 growth media were 
used in the illustration of light microphotograph (fig. 2a) and electron 
micrograph (fig. 2b); glycerol asparagine agar [39] and starch nitrate 
agar [24] respectively. The spore chain was found has an open hook 
shape that constructed from ellipsoidal spores which have a smooth 
surface. The motility of strain AD-7 had not been observed. The cell 
wall hydrolyses proved that LL-Diaminopimelic acid (LL-DAP) was 
present; however, the sugar pattern was not detected. 
  
Table 2: Cultural characteristics of AD-7 strain 
Media Growth rate Aerial mycelia Substrate mycelia Diffusible pigment 
Tryptone yeast extract agar  Good 264 lg 79 lgyYBr 79 lgyYBr 
Yeast-malt extract agar Good 263 lg 79 lgyYBr 79 lgyYBr 
Oat-meal extract agar Moderate 264 lg 76 lYBr 79 lgyYBr 
Inorganic salts starch agar Good 264 lg 79 lgyYBr 79 lgyYBr 
Glycerol asparagine  Poor 264 lg 79 lgyYBr 79 lgyYBr 
Peptone yeast extract iron agar Moderate 264 lg 79 lgyYBr 79 lgyYBr 
Tyrosine agar Poor 264 lg 76 lYBr 79 lgyYBr 
n = 3 
 
  
Fig. 2: (a) Microphotograph (x 1500) of actinomycete strain AD-7. (b) transmission electron micrograph (x 21 000) of actinomycete strain 
AD-7, n = 4 
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The strain AD-7 does not have the ability to produce the melanoid 
pigment, complete or partial reduction of nitrate, production of H2
On the other hand, the strain AD-7 was identified by detection of the 
encoded 16S rRNA gene of Streptomyces bacteria using PCR 
technique. The DNA was extracted according to Pitcher et al. [27], 
and then isolated and amplified according to Weisburg et al. [28]. 
S, 
and degradation of xanthin and esculin. Due to the nature of the 
strain habitat, it had been well grown on starch nitrate agar medium 
contained a high concentration of sodium chloride (5-15%). The 
strain AD-7 was found has a poor growth on Czapek's agar medium 
and high sensitivity to both of streptomycin and amoxicillin 
antibiotics (50 µg/ml). There different degrees of enzymatic activity 
were recorded, where cellulase and pectinase were highly produced, 
protease and coagulase were moderately produced; however, lipase 
was poorly produced and catalase was never secreted. D-glucose, D-
galactose, D-fructose, D-mannitol, Sucrose, L-arabinose, and L-
rhamnose were highly utilized; while, D-xylose and raffinose were 
moderately utilized and meso-inositol was poorly utilized. On the 
other hand, L-proline and L-tyrosine were highly utilized, L-
histidine, L-phenylalanine, and L-lysine were moderately utilized; 
however, L-alanine, L-valine, L-leucine, and L-cystiene were poorly 
utilized. 
The gene was separated as a single band at 1500 bp by agarose gel 
electrophoresis (fig. 3). According to the results of classical and 
molecular techniques, the actinomycete strain AD-7 was identified 
as Streptomyces coelicolor. Bentley et al. [40] reported that the 
complete sequencing for the full genome of Streptomyces coelicolor 
proved that this bacterium is considered a powerful producer for 
several secondary metabolites included α-glucosidase inhibitor. 
  
Table 3: Morphological, biochemical and physiological characteristics of AD-7 strain 
Characteristics Parameter Result 
Morphological Shape of spore chain Open hook 
Shape of spore Ellipsoidal 
Feel of spore surface Smooth 
Motility Non-motile 
Biochemical Type of DAP in the cell wall LL-DAP 
Sugar pattern in the cell wall Not detected 
Physiological Melanoid, nitrate, and H2 -ve S production 
Degradation of xanthin and esculin -ve 
NaCl tolerance (5-15%) +++ 
Growth on Czapek's agar + 
Streptomycin resistance (50 µg/ml) Sensitive 
Amoxicillin resistance (50 µg/ml) Sensitive 
Protease and coagulase production ++ 
Lipase production + 
Cellulase and pectinase production +++ 
Catalase production -ve 
D-glucose, D-galactose, D-fructose, D-mannitol, Sucrose, L-arabinose, and L-rhamnose +++ 
D-xylose and Raffinose ++ 
meso-Inositol + 
L-valine, L-alanine, L-leucine, and L-cysteine  + 
L-histidine, L-phenylalanine, and L-lysine ++ 
L-proline and L-tyrosine +++ 
n = 5; lg is light gray; lgyYBr is light gray yellowish brown; lYBr is light yellowish brown; -ve is not produced; +is poor; ++is moderate; +++is good  
 
Table 4: Assay the activity of an α-glucosidase inhibitor of mutant AD-7 strain 
Fc Ep (s) Inhibition activity (%)/d 
1 2st 3nd 4rd 5th 6th 7th 8th 9th 10th th 
1 5.0 2.3±0.18  3.0±0.24 3.7±0.26 4.5±0.31 3.8±0.26 3.1±0.24 2.3±0.18 1.6±0.15  1.0±0.11 0.7±0.06 
2 10 2.5±0.15 3.4±0.26 4.1±0.31 4.7±0.31 5.1±0.36 4.5±0.31 3.7±0.26 3.1±0.23 2.4±0.15 1.8±0.18 
3 15 2.1±0.18 2.8±0.15 3.5±0.26 4.1±0.31 4.7±0.31 3.9±0.29 3.2±0.26 2.4±0.15 1.8±0.18 1.1±0.11 
4 30 1.8±0.18 2.7±0.15 3.6±0.26 4.2±0.31 4.8±0.31 4.3±0.31 3.2±0.26 2.6±0.15 1.7±0.18 1.2±0.11 
n = 7; Fc is the fraction; Ep is the exposure period; ±SD 
 
 
Fig. 3: Agarose gel electrophoresis of amplified 16S rRNA gene 
of AD-7 strain, n = 6 
The genetic improvement was carried out by using UV rays (260 
nm) that have dominated the strain AD-7 for different time periods 
(5, 10, 15, and 30 s). The physical mutation showed promising 
results, where the improved α-glucosidase inhibitor was gotten 
especially at 10 s of the exposure period (table 4). 
However, there clear morphological changes were observed, where 
the number of colonies was inversely proportional with the 
exposure time, as well as, the color of aerial mycelia, substrate 
mycelia, and diffusible pigments was changed (fig. 4). Adepu [41] 
reported that, UV radiation was used to make a physical mutation 
for the Streptomyces gresioaurantiacus to increase β-glucosidase 
production. The maximum yield of an enzyme from the mutant 
strain was obtained within 94 h compared to the wild strain within 
120 h. Nevertheless, we have observed that S. gresioaurantiacus has 
a high resistance to the physical mutagenesis even at 60 min. 
Although a physical treatment was usually followed by a chemical 
one to avoid the reversible mutation [42], the mutant S. 
gresioaurantiacus was found has an irreversible physical mutation. 
Abdulkhair et al. 




Fig. 4: Morphological changes of mutant strain on agar medium 
due to exposure to UV rays at different time periods: (a) 5 s (b) 
10 s (c) 15 s (d) 30 s, n = 8 
Optimization study 
All optimum environmental factors were determined to obtain a 
maximum activity and stability of α-glucosidase inhibitor that 
produced by a mutant strain. The best incubation periods (fig. 5A), 
incubation temperature (fig. 5B), pH value (fig. 5C), inoculum size 
(fig. 5D), and agitation speed (fig. 5E) were determined at 14 d, 30 
°C, 8.5, 106 cfu/ml (300 µl), and 160 rpm respectively. Fei Ren et al. 
[43] stated that, the effect of pH on Streptomyces M37 growth and α-
glucosidase inhibitor production was determined, where the initial 
pH ranged from 6.5 to 8.5. The highest dry cell weight (DCW) (21.58 
g/l) was achieved at an initial pH of 7.0, and then decreased at pH up 
to 8.0. The maximum yield of α-glucosidase inhibitor (173.7 mg/l 
DCW) was obtained at an initial pH of 8.0. At 3345 mg/l, α-
glucosidase inhibitor production was higher at an initial pH of 8.0, 
than at other initial pH values. At the same time, specific α-
glucosidase inhibitor production (Cmax
 
 mg/l DCW) increased along 
with initial pH (in the 6.5 to 8.0 range). Accordingly, the high growth 
was correlated with a low initial pH, but on the other hand, the 
highest activity and productivity of α-glucosidase inhibitor were 
associated with a high initial pH value. These results were found 




Fig. 5: Effect of different optimum environmental factors on mutant AD-7 strain, n = 9 
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Purification and separation of α-glucosidase inhibitory protein 
Many studies which have been conducted in this field isolated and 
purified an intracellular α-glucosidase inhibitor. However, the 
concerned α-glucosidase inhibitor in this study is an extracellular 
secondary metabolite that has a peptide nature. The stepwise 
purification process was carried out by using diethyl-aminoethyl-
cellulose and sephadex G 200 in an ion exchange and gel filtration 
column chromatography respectively. The purified protein was 
separated as a single band at 34 KDa by using sodium-dodecyl-
sulphate-polyacrylamide gel electrophoresis (fig. 6). Therefore, 
there is a new fact has been recorded, where there are two types of 
α-glucosidase inhibitor according to the secretion site; intracellular 
and extracellular α-glucosidase inhibitor. 
 
 
Fig. 6: Separation of α-glucosidase inhibitory protein by SDS-
PAGE, n = 10 
 
CONCLUSION 
Among 55 marine actinomycete strains which isolated from the 
sediment samples of the Red Sea, only 7 antidiabetic strains were 
present included a most potent strain that symbolized AD-7, which 
identified by using classical and molecular techniques as S. 
coelicolor. The genetic improvement of the latter had been carried 
out by using UV radiations, where the more active and more stable 
α-glucosidase inhibitor was obtained. All optimum environmental 
conditions were determined to increase the productivity of an 
inhibitor. Eventually, an inhibitor was purified and separated as a 
single band at 34 KDa. 
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